Dynamic and Static Simulations of Fluvoxamine-Perpetrated Drug-Drug Interactions Using Multiple Cytochrome P450 Inhibition Modeling, and Determination of Perpetrator-Specific CYP Isoform Inhibition Constants and Fractional CYP Isoform Contributions to Victim Clearance-Reference-Cited by-同舟云学术

Dynamic and Static Simulations of Fluvoxamine-Perpetrated Drug-Drug Interactions Using Multiple Cytochrome P450 Inhibition Modeling, and Determination of Perpetrator-Specific CYP Isoform Inhibition Constants and Fractional CYP Isoform Contributions to Victim Clearance

Published:2016-03 Issue:3 Volume:105 Page:1307-1317
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Iga Katsumi

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference30 articles.

1. Efficacy and clinical safety of ramelteon: an evidence-based review;Sateia;Sleep Med Rev,2008

2. Use of three-compartment physiologically based pharmacokinetic modeling to predict hepatic blood levels of fluvoxamine relevant for drug-drug interactions;Iga;J Pharm Sci,2015

3. Simulation of metabolic drug-drug interactions perpetrated by fluvoxamine using hybridized two-compartment hepatic drug-pool-based tube modeling and estimation of in vivo inhibition constants;Iga;J Pharm Sci,2015

4. The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions;Obach;J Pharmacol Exp Ther,2006

5. Metabolism of ramelteon in human liver microsomes and correlation with the effect of fluvoxamine on ramelteon pharmacokinetics;Obach;Drug Metab Dispos,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interplay of UDP-Glucuronosyltransferase and CYP2C8 for CYP2C8 Mediated Drug Oxidation and Its Impact on Drug–Drug Interaction Produced by Standardized CYP2C8 Inhibitors, Clopidogrel and Gemfibrozil;Clinical Pharmacokinetics;2023-11-03

2. Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications;Metabolites;2023-07-29

3. Comparative analysis of CYP2C8-medidated drug-drug interactions produced by CYP2C8 inhibitors, gemfibrozil versus clopidogrel, focusing on the inhibition of drug distribution in UDP-glucuronosyltransferase prior to oxidation;2023-01-09

4. Disease-drug and drug-drug interaction in COVID-19: Risk and assessment;Biomedicine & Pharmacotherapy;2021-07

5. A Physiologically-Based Pharmacokinetic (PBPK) Model Network for the Prediction of CYP1A2 and CYP2C19 Drug–Drug–Gene Interactions with Fluvoxamine, Omeprazole, S-mephenytoin, Moclobemide, Tizanidine, Mexiletine, Ethinylestradiol, and Caffeine;Pharmaceutics;2020-12-08